Anti-abortion campaigners are pressing ahead with a controversial amendment to the Government’s new health bill designed to cut the number of pregnancies which are terminated each year in the UK. The Conservative MP Nadine Dorries, who is proposing the amendment, said yesterday she would not be “bought off” by the promise of a Government consultation on whether or not to offer independent counselling to all women considering an abortion. Instead she said she wanted to change the law to strip abortion charities and doctors of their exclusive responsibility for counselling women seeking to terminate a pregnancy, and hand it to specially trained professionals.
'A new pathway for the regulation and governance of health research' was published in January 2011. The report was prepared by a working group, chaired by Professor Sir Michael Rawlins FMedSci, convened in response to an invitation from Government to review the regulation and governance of UK health research involving human participants, their tissue or their data. The report proposes four key principles that should underpin the regulation and governance framework around health research in the UK, and makes recommendations to: * Create a new Health Research Agency (HRA) to rationalise the regulation and governance of all health research. * Include within the HRA a new National Research Governance Service to facilitate timely approval of research studies by NHS Trusts. * Improve the UK environment for clinical trials. * Provide access to patient data that protects individual interests and allows approved research to proceed effectively. * Embed a culture that value
[...] the Panel was persuaded that the law in Canada [...] should be changed to allow some form of assisted suicide and voluntary euthanasia. Putting the philosophical analysis together with the lessons learned from [a] review of the paths taken in other jurisdictions that have moved to more permissive regimes, the Panel considered the options for the design of a permissive regime and suggests the following legal mechanisms for achieving the reform and the core elements of the proposed reform.
“The current legal status of assisted dying is inadequate and incoherent...” The Commission on Assisted Dying was set up in September 2010 to consider whether the current legal and policy approach to assisted dying in England and Wales is fit for purpose. In addition to evaluating the strengths and weaknesses of the legal status quo, the Commission also set out to explore the question of what a framework for assisted dying might look like, if such a system were to be implemented in the UK, and what approach to assisted dying might be most acceptable to health and social care professionals and to the general public.
The treatment of inherited mitochondrial abnormalities in human embryos using donor mitochondria is an advancing area of research. The techniques involved could have profound implications for future generations. This project will explore the ethical issues relevant to affected families, potential donors, researchers, medical professionals and others trying to understand and respond to the therapeutic possibility of mitochondrial transfer.
The Medical Practitioners Tribunal Service is the new adjudication service for UK doctors. This site contains information and advice on the role of the MPTS, including the schedule of forthcoming hearings and recent decisions by the panels.
Standards should never come into question, but it's clear to this Government that NHS administrative costs can be streamlined. Estimates suggest that savings of over £180 million could be delivered by 2015 by reducing the number of NHS bodies, including arm's-length bodies. And that is why I set out proposals to change responsibility for regulating fertility treatment and human tissue last week. The UK-wide consultation will consider whether the responsibilities of the regulators - the Human Fertilisation and Embryology Authority (HFEA) and Human Tissue Authority (HTA) - should move to the Care Quality Commission (CQC) and the Health Research Authority (HRA).
The present paper constitutes the input of Alzheimer Europe and its member organisations to the ongoing discussions within Europe about advance directives (in the context of Alzheimer’s disease and other forms of dementia). It is the result of discussions carried out in a multidisciplinary group, comprising experts in the field of psychiatry, neurology, pharmacology, psychology, law and ethics, in collaboration with the Board of Alzheimer Europe and its member associations. Please see Annex 1 for the list of participants of the working group. Alzheimer Europe’s position on advance directives was guided by several general principles and was influenced by principles contained in pre-existing European or international documents. Please refer to section D for details. On the basis of these principles and of a review of current literature concerning issues linked to the use of advance directives, Alzheimer Europe has developed the following position with regard to advance directives.
Un débat interne à l’ensemble de l’Institution ordinale a été conduit avant cette expression publique. Il en résulte que la fin de la vie d’une personne dans ces situations implique profondément le corps médical selon les principes éthiques de bienfaisance et d’humanité. L’Ordre national des médecins propose donc de promouvoir une meilleure connaissance de la loi Leonetti et d’envisager des améliorations susceptibles de répondre à des situations exceptionnelles. L’Ordre national des médecins apportera sa contribution au débat sociétal quant à l’euthanasie délibérée et au suicide assisté.
Rechtsonzekerheid voor artsen bij uitvoering euthanasie onacceptabel Artsen houden zich goed aan de euthanasiewet, zo blijkt uit de tweede evaluatie van deze wet. Maar zij worden geconfronteerd met rechtsonzekerheid over het toetsingskader. Daarom steunt de KNMG de aanbeveling van een code of practice voor de toetsingscommissies en dringt zij aan op duidelijkheid over de waarde van de schriftelijke wilsverklaring bij wilsonbekwame patiënten. De KNMG reageert hiermee op de tweede evaluatie van de Wet toetsing levensbeëindiging op verzoek en hulp bij zelfdoding (Wtl).
The Emerging Science and Bioethics Advisory Committee (ESBAC) was the main UK advisory body on emerging healthcare scientific developments and their ethical, legal, social and economic implications. It was sponsored by the Chief Medical Officer (CMO) for the Department of Health (DH), England. Its membership included representation from all UK Health Departments for whom ESBAC also provided advice. ESBAC also provided a forum to consider and develop coordinated advice across the wider science, health and academic communities to help set priorities in response to new developments.